APO Research
Talk to an analyst

APO RESEARCH · REPORT

Juvenile Idiopathic Arthritis Diagnostic

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Juvenile Idiopathic Arthritis Diagnostic Market Analysis and Forecast 2026-2032

27 December 2025193 pages

Choose your research edition.

Industry ResearchJuvenile Idiopathic Arthritis Diagnostic Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Juvenile Idiopathic Arthritis Diagnostic Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Juvenile Idiopathic Arthritis Diagnostic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Juvenile Idiopathic Arthritis Diagnostic Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Juvenile Idiopathic Arthritis Diagnostic Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Juvenile Idiopathic Arthritis Diagnostic market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Juvenile Idiopathic Arthritis Diagnostic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Juvenile Idiopathic Arthritis Diagnostic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Juvenile Idiopathic Arthritis Diagnostic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Juvenile Idiopathic Arthritis Diagnostic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Juvenile Idiopathic Arthritis Diagnostic include Abbott, Roche, United Imaging, Philips, Thermo Fisher Scientific, Sysmex, Siemens Healthineers, Siemens and Hitachi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Juvenile Idiopathic Arthritis Diagnostic, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Juvenile Idiopathic Arthritis Diagnostic, also provides the revenue of main regions and countries. Of the upcoming market potential for Juvenile Idiopathic Arthritis Diagnostic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Juvenile Idiopathic Arthritis Diagnostic revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Juvenile Idiopathic Arthritis Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Juvenile Idiopathic Arthritis Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Juvenile Idiopathic Arthritis Diagnostic Segment by Company

Abbott

Roche

United Imaging

Philips

Thermo Fisher Scientific

Sysmex

Siemens Healthineers

Siemens

Hitachi

GE

Danaher

Canon Medical

BioMerieux

Juvenile Idiopathic Arthritis Diagnostic Segment by Type

Blood Tests

Imaging Scans

Juvenile Idiopathic Arthritis Diagnostic Segment by Application

Hospitals

Laboratories

Other

Juvenile Idiopathic Arthritis Diagnostic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Juvenile Idiopathic Arthritis Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Juvenile Idiopathic Arthritis Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Juvenile Idiopathic Arthritis Diagnostic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Juvenile Idiopathic Arthritis Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Juvenile Idiopathic Arthritis Diagnostic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Juvenile Idiopathic Arthritis Diagnostic revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Tests Major Player Table 3. Imaging Scans Major Player Table 4. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Laboratories Major Player Table 7. Other Major Player Table 8. Juvenile Idiopathic Arthritis Diagnostic Industry Trends Table 9. Juvenile Idiopathic Arthritis Diagnostic Industry Drivers Table 10. Juvenile Idiopathic Arthritis Diagnostic Industry Opportunities and Challenges Table 11. Juvenile Idiopathic Arthritis Diagnostic Industry Restraints Table 12. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021-2026) Table 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2027-2032) Table 17. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Players (2021-2026) Table 19. Global Juvenile Idiopathic Arthritis Diagnostic Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Juvenile Idiopathic Arthritis Diagnostic Key Players Headquarters & Area Served Table 21. Global Juvenile Idiopathic Arthritis Diagnostic Players, Product Type & Application Table 22. Global Juvenile Idiopathic Arthritis Diagnostic Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Juvenile Idiopathic Arthritis Diagnostic by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2021-2026) Table 29. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2027-2032) Table 30. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021-2026) Table 34. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2027-2032) Table 35. Abbott Company Information Table 36. Abbott Business Overview Table 37. Abbott Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 39. Abbott Recent Development Table 40. Roche Company Information Table 41. Roche Business Overview Table 42. Roche Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Roche Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 44. Roche Recent Development Table 45. United Imaging Company Information Table 46. United Imaging Business Overview Table 47. United Imaging Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. United Imaging Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 49. United Imaging Recent Development Table 50. Philips Company Information Table 51. Philips Business Overview Table 52. Philips Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Philips Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 54. Philips Recent Development Table 55. Thermo Fisher Scientific Company Information Table 56. Thermo Fisher Scientific Business Overview Table 57. Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 59. Thermo Fisher Scientific Recent Development Table 60. Sysmex Company Information Table 61. Sysmex Business Overview Table 62. Sysmex Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sysmex Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 64. Sysmex Recent Development Table 65. Siemens Healthineers Company Information Table 66. Siemens Healthineers Business Overview Table 67. Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 69. Siemens Healthineers Recent Development Table 70. Siemens Company Information Table 71. Siemens Business Overview Table 72. Siemens Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Siemens Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 74. Siemens Recent Development Table 75. Hitachi Company Information Table 76. Hitachi Business Overview Table 77. Hitachi Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Hitachi Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 79. Hitachi Recent Development Table 80. GE Company Information Table 81. GE Business Overview Table 82. GE Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GE Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 84. GE Recent Development Table 85. Danaher Company Information Table 86. Danaher Business Overview Table 87. Danaher Juvenile Idiopathic Arthritis Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Danaher Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 89. Danaher Recent Development Table 90. Canon Medical Company Information Table 91. Canon Medical Business Overview Table 92. Canon Medical Juvenile Idiopathic Arthritis Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Canon Medical Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 94. Canon Medical Recent Development Table 95. BioMerieux Company Information Table 96. BioMerieux Business Overview Table 97. BioMerieux Juvenile Idiopathic Arthritis Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. BioMerieux Juvenile Idiopathic Arthritis Diagnostic Product Portfolio Table 99. BioMerieux Recent Development Table 100. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (US$ Million) & (2027-2032) Table 114. China Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 115. China Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 116. China Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 117. China Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Juvenile Idiopathic Arthritis Diagnostic Image Figure 2. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Tests Image Figure 5. Imaging Scans Image Figure 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Laboratories Image Figure 10. Other Image Figure 11. Global Juvenile Idiopathic Arthritis Diagnostic Market Size (US$ Million) & (2021-2032) Figure 12. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Juvenile Idiopathic Arthritis Diagnostic Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2021-2032) Figure 19. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021-2032) Figure 22. North America Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032) Figure 24. North America Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032) Figure 25. North America Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Country (2021-2032) Figure 26. United States Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032) Figure 31. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032) Figure 32. Europe Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Country (2021-2032) Figure 33. Germany Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032) Figure 43. China Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032) Figure 44. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032) Figure 46. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032) Figure 47. Asia Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Region (2021-2032) Figure 48. Japan Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032) Figure 56. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032) Figure 57. SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Country (2021-2032) Figure 58. Brazil Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Juvenile Idiopathic Arthritis Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Tests
  • Imaging Scans
Applications
  • Hospitals
  • Laboratories
  • Other
Companies covered
  • Abbott
  • Roche
  • United Imaging
  • Philips
  • Thermo Fisher Scientific
  • Sysmex
  • Siemens Healthineers
  • Siemens
  • Hitachi
  • GE
  • Danaher
  • Canon Medical
  • BioMerieux

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Juvenile Idiopathic Arthritis Diagnostic Market by Type
  3. 1.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Tests
  5. 1.2.3 Imaging Scans
  6. 1.3 Juvenile Idiopathic Arthritis Diagnostic Market by Application
  7. 1.3.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Laboratories
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Juvenile Idiopathic Arthritis Diagnostic Market Dynamics
  1. 2.1 Juvenile Idiopathic Arthritis Diagnostic Industry Trends
  2. 2.2 Juvenile Idiopathic Arthritis Diagnostic Industry Drivers
  3. 2.3 Juvenile Idiopathic Arthritis Diagnostic Industry Opportunities and Challenges
  4. 2.4 Juvenile Idiopathic Arthritis Diagnostic Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Perspective (2021-2032)
  2. 3.2 Global Juvenile Idiopathic Arthritis Diagnostic Growth Trends by Region
  3. 3.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2021-2026)
  5. 3.2.3 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Players
  2. 4.1.1 Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Players (2021-2026)
  3. 4.1.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Juvenile Idiopathic Arthritis Diagnostic Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Juvenile Idiopathic Arthritis Diagnostic Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Juvenile Idiopathic Arthritis Diagnostic Key Players Headquarters & Area Served
  7. 4.4 Global Juvenile Idiopathic Arthritis Diagnostic Players, Product Type & Application
  8. 4.5 Global Juvenile Idiopathic Arthritis Diagnostic Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Juvenile Idiopathic Arthritis Diagnostic Market CR5 and HHI
  11. 4.6.3 2025 Juvenile Idiopathic Arthritis Diagnostic Tier 1, Tier 2, and Tier 3
5 Juvenile Idiopathic Arthritis Diagnostic Market Size by Type
  1. 5.1 Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2032)
  3. 5.3 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2021-2032)
6 Juvenile Idiopathic Arthritis Diagnostic Market Size by Application
  1. 6.1 Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2032)
  3. 6.3 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 United Imaging
  14. 7.3.1 United Imaging Company Information
  15. 7.3.2 United Imaging Business Overview
  16. 7.3.3 United Imaging Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  17. 7.3.4 United Imaging Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  18. 7.3.5 United Imaging Recent Developments
  19. 7.4 Philips
  20. 7.4.1 Philips Company Information
  21. 7.4.2 Philips Business Overview
  22. 7.4.3 Philips Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Philips Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  24. 7.4.5 Philips Recent Developments
  25. 7.5 Thermo Fisher Scientific
  26. 7.5.1 Thermo Fisher Scientific Company Information
  27. 7.5.2 Thermo Fisher Scientific Business Overview
  28. 7.5.3 Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  30. 7.5.5 Thermo Fisher Scientific Recent Developments
  31. 7.6 Sysmex
  32. 7.6.1 Sysmex Company Information
  33. 7.6.2 Sysmex Business Overview
  34. 7.6.3 Sysmex Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sysmex Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  36. 7.6.5 Sysmex Recent Developments
  37. 7.7 Siemens Healthineers
  38. 7.7.1 Siemens Healthineers Company Information
  39. 7.7.2 Siemens Healthineers Business Overview
  40. 7.7.3 Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  42. 7.7.5 Siemens Healthineers Recent Developments
  43. 7.8 Siemens
  44. 7.8.1 Siemens Company Information
  45. 7.8.2 Siemens Business Overview
  46. 7.8.3 Siemens Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Siemens Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  48. 7.8.5 Siemens Recent Developments
  49. 7.9 Hitachi
  50. 7.9.1 Hitachi Company Information
  51. 7.9.2 Hitachi Business Overview
  52. 7.9.3 Hitachi Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hitachi Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  54. 7.9.5 Hitachi Recent Developments
  55. 7.10 GE
  56. 7.10.1 GE Company Information
  57. 7.10.2 GE Business Overview
  58. 7.10.3 GE Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GE Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  60. 7.10.5 GE Recent Developments
  61. 7.11 Danaher
  62. 7.11.1 Danaher Company Information
  63. 7.11.2 Danaher Business Overview
  64. 7.11.3 Danaher Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Danaher Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  66. 7.11.5 Danaher Recent Developments
  67. 7.12 Canon Medical
  68. 7.12.1 Canon Medical Company Information
  69. 7.12.2 Canon Medical Business Overview
  70. 7.12.3 Canon Medical Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Canon Medical Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  72. 7.12.5 Canon Medical Recent Developments
  73. 7.13 BioMerieux
  74. 7.13.1 BioMerieux Company Information
  75. 7.13.2 BioMerieux Business Overview
  76. 7.13.3 BioMerieux Juvenile Idiopathic Arthritis Diagnostic Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BioMerieux Juvenile Idiopathic Arthritis Diagnostic Product Portfolio
  78. 7.13.5 BioMerieux Recent Developments
8 North America
  1. 8.1 North America Juvenile Idiopathic Arthritis Diagnostic Revenue (2021-2032)
  2. 8.2 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2032)
  3. 8.2.1 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026)
  4. 8.2.2 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032)
  5. 8.3 North America Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032)
  6. 8.4 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2032)
  7. 8.4.1 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026)
  8. 8.4.2 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032)
  9. 8.5 North America Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032)
  10. 8.6 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country
  11. 8.6.1 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026)
  13. 8.6.3 North America Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue (2021-2032)
  2. 9.2 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2032)
  3. 9.2.1 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026)
  4. 9.2.2 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032)
  5. 9.3 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032)
  6. 9.4 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2032)
  7. 9.4.1 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026)
  8. 9.4.2 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032)
  9. 9.5 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032)
  10. 9.6 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country
  11. 9.6.1 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026)
  13. 9.6.3 Europe Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Juvenile Idiopathic Arthritis Diagnostic Revenue (2021-2032)
  2. 10.2 China Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2032)
  3. 10.2.1 China Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026)
  4. 10.2.2 China Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032)
  5. 10.3 China Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032)
  6. 10.4 China Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2032)
  7. 10.4.1 China Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026)
  8. 10.4.2 China Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032)
  9. 10.5 China Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue (2021-2032)
  2. 11.2 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2032)
  3. 11.2.1 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026)
  4. 11.2.2 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032)
  5. 11.3 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032)
  6. 11.4 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2032)
  7. 11.4.1 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026)
  8. 11.4.2 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032)
  9. 11.5 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032)
  10. 11.6 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Country
  11. 11.6.1 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026)
  13. 11.6.3 Asia Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue (2021-2032)
  2. 12.2 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Type (2027-2032)
  5. 12.3 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Application (2027-2032)
  9. 12.5 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country
  11. 12.6.1 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Juvenile Idiopathic Arthritis Diagnostic Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst